DoD's $20.2M Biotechnology R&D Contract Awarded to Leidos, Inc. for Deployment Health Research
Contract Overview
Contract Amount: $20,231,991 ($20.2M)
Contractor: Leidos, Inc.
Awarding Agency: Department of Defense
Start Date: 2024-08-28
End Date: 2026-08-27
Contract Duration: 729 days
Daily Burn Rate: $27.8K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 3
Pricing Type: COST PLUS FIXED FEE
Sector: R&D
Official Description: DEPLOYMENT HEALTH RESEARCH
Place of Performance
Location: RESTON, FAIRFAX County, VIRGINIA, 20190
State: Virginia Government Spending
Plain-Language Summary
Department of Defense obligated $20.2 million to LEIDOS, INC. for work described as: DEPLOYMENT HEALTH RESEARCH Key points: 1. Leidos, Inc. secured a significant contract for specialized biotechnology research. 2. The contract falls under the Research and Development in Biotechnology sector. 3. Full and open competition was utilized, suggesting a competitive bidding process. 4. The contract duration is 729 days, indicating a medium-term project.
Value Assessment
Rating: good
The contract's Cost Plus Fixed Fee (CPFF) pricing structure is common for R&D, allowing for flexibility. Benchmarking against similar CPFF contracts in biotech R&D is needed for a precise value assessment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, which typically fosters competitive pricing and ensures the government receives the best value. The specific price discovery mechanisms within this competitive process would need further examination.
Taxpayer Impact: Taxpayer funds are being utilized for critical research and development in biotechnology, aiming for advancements in deployment health.
Public Impact
Advancements in deployment health research could lead to improved well-being for military personnel. Investment in biotechnology R&D supports innovation and technological progress within the defense sector. The contract award to Leidos, Inc. highlights the role of private sector expertise in government research initiatives.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for cost overruns inherent in CPFF contracts.
- Reliance on a single contractor for a critical research area.
Positive Signals
- Awarded through full and open competition.
- Focus on a critical area of defense research.
Sector Analysis
This contract is within the Biotechnology R&D sector, a high-growth area with significant government investment. Spending benchmarks for similar R&D contracts can vary widely based on scope and complexity.
Small Business Impact
The data indicates this contract was not awarded to small businesses. Further analysis would be needed to determine if subcontracting opportunities exist for small businesses within this larger award.
Oversight & Accountability
Oversight will be crucial to ensure the research objectives are met efficiently and within budget, given the CPFF structure. The Department of the Navy will be responsible for monitoring contractor performance and expenditures.
Related Government Programs
- Research and Development in Biotechnology (except Nanobiotechnology)
- Department of Defense Contracting
- Department of the Navy Programs
Risk Flags
- Cost Plus Fixed Fee (CPFF) pricing can lead to cost overruns if not managed carefully.
- The specific deliverables and success metrics for this R&D contract need clear definition.
- Potential for intellectual property disputes in R&D contracts.
- Dependence on Leidos, Inc.'s specialized expertise.
Tags
research-and-development-in-biotechnolog, department-of-defense, va, delivery-order, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Defense awarded $20.2 million to LEIDOS, INC.. DEPLOYMENT HEALTH RESEARCH
Who is the contractor on this award?
The obligated recipient is LEIDOS, INC..
Which agency awarded this contract?
Awarding agency: Department of Defense (Department of the Navy).
What is the total obligated amount?
The obligated amount is $20.2 million.
What is the period of performance?
Start: 2024-08-28. End: 2026-08-27.
What specific deployment health challenges does this research aim to address, and what are the expected outcomes?
The research aims to address critical health challenges faced by deployed military personnel, potentially including infectious diseases, environmental health risks, or psychological well-being. Expected outcomes could range from new diagnostic tools and treatments to improved preventative measures and operational guidelines, ultimately enhancing soldier readiness and long-term health.
How does the CPFF pricing structure mitigate risks associated with R&D uncertainty while ensuring cost control?
The CPFF structure allows for flexibility in R&D where exact costs are unpredictable, covering allowable costs plus a fixed fee. Risk mitigation involves robust government oversight, clear performance metrics, and defined scope. Cost control relies on the fixed fee incentivizing efficiency, but requires diligent monitoring to prevent scope creep or unnecessary expenditures.
What is the potential long-term impact of this research on military healthcare and operational readiness?
Successful research outcomes could significantly improve military healthcare by providing advanced solutions for health threats encountered during deployments. This directly translates to enhanced operational readiness, as healthier service members are more capable of fulfilling their missions. Long-term, it could also reduce healthcare burdens and improve the quality of life for veterans.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in Biotechnology (except Nanobiotechnology)
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Solicitation ID: N0018924QZ089
Offers Received: 3
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Parent Company: Leidos Holdings, Inc.
Address: 1750 PRESIDENTS ST, RESTON, VA, 20190
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $87,336,531
Exercised Options: $30,277,151
Current Obligation: $20,231,991
Subaward Activity
Number of Subawards: 1
Total Subaward Amount: $59,565
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: HT001122D0028
IDV Type: IDC
Timeline
Start Date: 2024-08-28
Current End Date: 2026-08-27
Potential End Date: 2030-02-28 00:00:00
Last Modified: 2026-01-09
More Contracts from Leidos, Inc.
- Science Operation and Maintenance Support for the United States Antarctic Program — $3.1B (National Science Foundation)
- Provide Funding for Clin 302 for Pre-Flight and In-Flight Services. Contract Number Dtfawa-05-C-00031, Lockheed Martin. POP 01/16/08-03/31/08 — $1.9B (Department of Transportation)
- THE Facilities Development and Operations Contract(fdoc) Specifies Technical, Managerial, and Adminstrative Work Needed to Ensure the Availablitity, Integrity, and Reliability of Missionoperations Facilites Supporting National Aeronautics and Space Administration (nasa) Human Space Flight (HSF) Programs Requiring Mission Operations Support. the Objective of This Contract IS to Consolidate Efforts Across the Facilities Covered Under Fodoc in Order to Maximize Synergy for Hardware and Software Development, Modification, Sustaining. Maintenance, Reconfiguration, and Operations for the Purpose of Reducing Cost Without Compromising Facility Functionality and Performance. Nasa Will Collaborate With the Contractor on Developing Procedural and Technical Innovations That Improve Quality, Ensure Customer Satisfaction and Reduce Cost. Mission Operations Facilities Currently Support the Space Shuttle Programand the International Space Station Progra, Including International Partner and Commmercial Visiting Vehicles. Mission Operations Facilities Supporting the Cnstellation Program(cxp) ARE Continuously Under Development in Concert With CXP Formulation and Implementation. Fdoc Applies to the Facilities of These Three Programs, and ANY Other HSF Program Requiring Mission Operations Facility Support. in Addition, Future Mission Operations Facilities and Capabilities ARE Within the Technical Scope of This SOW, and Fdoc Worlk Associated With These Facilities Will BE Enabled Through Idiq — $1.3B (National Aeronautics and Space Administration)
- National Airspace System (NAS) Implementation Support Contract (nisc). Provides Engineering and Technical Support Services to FAA Organizations Responsible for NAS Transformation, Integration and Implementation in the Areas of Implementation and Integration Planning, Transition Planning, Engineering Support, Environmental Support, Automation Support and Other Engineering and Technical Disciplines AS Required. TAS::69 8107::TAS — $1.1B (Department of Transportation)
- Itssc Task Order for Systems — $1.1B (Social Security Administration)
Other Department of Defense Contracts
- Federal Contract — $51.3B (Humana Government Business Inc)
- Lrip LOT 12 Advance Acquisition Contract — $35.1B (Lockheed Martin Corporation)
- SSN 802 and 803 Long Lead Time Material — $34.7B (Electric Boat Corporation)
- 200204!008532!1700!AF600 !naval AIR Systems Command !N0001902C3002 !A!N! !N! !20011026!20120430!008016958!008016958!834951691!n!lockheed Martin Corporation !lockheed Blvd !fort Worth !tx!76108!27000!439!48!fort Worth !tarrant !texas !+000026000000!n!n!018981928201!ac15!rdte/Aircraft-Eng/Manuf Develop !a1a!airframes and Spares !2ama!jast/Jsf !336411!E! !3! ! ! ! ! !99990909!B! ! !A! !a!n!r!2!002!n!1a!a!n!z! ! !N!C!N! ! ! !a!a!a!a!000!a!c!n! ! ! !Y! !N00019!0001! — $34.2B (Lockheed Martin Corporation)
- KC-X Modernization Program — $32.0B (THE Boeing Company)